$OKLO

Oklo Inc (OKLO) (Q2 2026) Earnings Call Highlights: Record Criticality Milestone

Oklo Inc (NYSE:OKLO) reported a Q2 2026 earnings call with a year-to-date net loss of $81.6 million and operating cash used of $65.5 million. The company raised 2026 operating cash flow guidance to $120-$150 million and PP&E spending to $400-$500 million. DOE plutonium allocation timing remains uncertain; first isotope revenue is expected in early 2027.

Original reporting
Published Aug 7, 2026, 9:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 12:38 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Oklo Inc (OKLO) (Q2 2026) Earnings Call Highlights: Record Criticality Milestone — source image
Decision brief

The 30-second read

$OKLONeutralMed
01

Why it matters

The most tradable elements are the updated 2026 cash flow and PP&E ranges, plus explicit statements that full Aurora-INL cost guidance is not yet provided and that PJM interconnection turnaround time is the key watch point.

02

Market read

Traders can update models for Oklo’s 2026 cash burn and CapEx intensity, while monitoring fuel allocation and interconnection timing risks that could affect 2028 startup and isotope monetization.

03

What to watch

The call suggests fuel assurance at full power via EBR-II recovered material and evolving plutonium pathway, but the market may over-focus on DOE timing while underweighting the multi-pronged fuel strategy and customer payment progress (Meta, Equinix).

Relevance 7/10Novelty 6/10Timing: post-market earnings call, guidance and project milestones discussed for 2026-2028

Background

Oklo’s Q2 2026 earnings call focused on Aurora-INL capital deployment, DOE plutonium allocation uncertainty, Groves criticality results, and isotope revenue timing.

Company-level read

Ticker impact

$OKLONeutralMedium confidence
Context

Oklo raised 2026 operating cash flow guidance to $120-$150M and PP&E to $400-$500M, signaling higher cash burn tied to Aurora-INL.

Expected impact

Likely choppy trading, with upside from guidance confidence offset by concerns over DOE plutonium timing, missing full cost guidance, and interconnection delay risk.

Evidence & confidence

The call provides concrete forward-looking ranges and project-critical details (grid interconnection, fuel strategy, PJM watch points), but also highlights multiple timing uncertainties (DOE allocation, Aurora-INL total cost, PJM turnaround, isotope revenue timing).

Market effects

Reinforces that advanced reactor developers face intertwined constraints: DOE fuel allocation uncertainty, long-lead grid interconnection, and interconnection queue timing.

Ohio campus power delivery timeline risk is tied to PJM interconnection turnaround backlog.

Highlights US nuclear fuel lifecycle and isotope monetization timelines, relevant to broader advanced nuclear and radioisotope supply chains.

Counterpoint

The higher 2026 operating cash flow and the CEO’s criticality milestone validation could improve credibility with offtake counterparties, outweighing near-term cash burn concerns.

Key entities

  • Oklo Inc

    Advanced nuclear and radioisotope developer; discussed updated 2026 cash flow and PP&E guidance, Aurora-INL execution, DOE plutonium allocation uncertainty, and isotope revenue roadmap.

  • Meta

    Referenced as having made customer payments on the power side, indicating more advanced commercial discussions.

  • Equinix

    Referenced as having made customer payments on the power side, supporting near-term commercial momentum.

  • PJM Interconnection

    Oklo is participating in the interconnection process; turnaround time is flagged as the key watch point.

  • Kiewit

    Oklo is working with Kiewit while narrowing total Aurora-INL cost, with full cost guidance expected later this year.

Related articles

$OKLOMed

Oklo Inc. Q2 2026 Earnings Call Summary

Oklo Inc. reported progress from its Q2 2026 earnings call, including first criticality at the Groves isotope facility and plans for Aurora deployments at INL and an Ohio clean energy campus. The company targeted 2028 commercial startup, expected first isotope revenue in early 2027, and raised 2026 operating cash use guidance to $120M-$150M and PP&E spend to $400M-$500M.

$OKLOMed

Oklo Stock Attempts a Turnaround, but Technical Barriers Remain as It Releases Q2 2026 Financial Results

Oklo reported Q2 2026 revenue of $1.2 million, above analysts’ ~$83,800 estimate, but posted a $0.28 per-share loss versus a ~$0.16 consensus. Net loss widened to $48.5 million from $24.7 million a year earlier. The company ended the quarter with about $3 billion in cash and marketable securities and said its Groves Isotope Test Reactor achieved first criticality.

$OKLOMedAI 8/10

Oklo reports $1.21M Q2 revenue, $1.6B cash as Aurora milestones advance

Oklo Inc. (NYSE: OKLO) reported Q2 2026 revenue of $1.21M versus a $126,250 analyst estimate and an EPS loss of $(0.28) versus an estimated $(0.16). The company said it ended the quarter with $1.6B cash and expects 2026 operating cash flow of $120M to $150M and capex of $400M to $500M. It also advanced Aurora regulatory steps and said its Groves reactor reached first criticality.

$OKLOMed

Oklo's Groves Reactor Just Achieved First Criticality. Here's What It Means for OKLO Stock.

Oklo said its Groves Isotope Test Reactor in Texas achieved first criticality on Aug. 5, marking the first self-sustaining fission chain reaction at the Groves site, according to the company. Oklo noted it was the first DOE Reactor Pilot Program project to reach criticality from a greenfield private-land site. The firm reiterated targets for Aurora-INL late 2027 to early 2028 and Aurora-Ohio startup in early 2030.

$OKLOMedAI 8/10

OKLO Q2 FY2026 earnings call — BigGo Finance

Oklo Inc. reported a first-half 2026 net loss of $81.6 million, with operating loss of $124.2 million offset by $44.5 million of net interest and dividend income, and no revenue recognized. Cash and marketable securities were $3.0 billion at June 30, 2026. Management raised FY2026 operating cash use to $120 million-$150 million and capex to $400 million-$500 million. Key updates include Groves first criticality and DOE progress for Aurora-INL.